1. Home
  2. FTRE vs GIII Comparison

FTRE vs GIII Comparison

Compare FTRE & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • GIII
  • Stock Information
  • Founded
  • FTRE 1996
  • GIII 1956
  • Country
  • FTRE United States
  • GIII United States
  • Employees
  • FTRE N/A
  • GIII N/A
  • Industry
  • FTRE Medical Specialities
  • GIII Apparel
  • Sector
  • FTRE Health Care
  • GIII Consumer Discretionary
  • Exchange
  • FTRE Nasdaq
  • GIII Nasdaq
  • Market Cap
  • FTRE 1.4B
  • GIII 1.4B
  • IPO Year
  • FTRE N/A
  • GIII 1989
  • Fundamental
  • Price
  • FTRE $9.58
  • GIII $26.10
  • Analyst Decision
  • FTRE Hold
  • GIII Hold
  • Analyst Count
  • FTRE 11
  • GIII 7
  • Target Price
  • FTRE $20.30
  • GIII $33.43
  • AVG Volume (30 Days)
  • FTRE 2.2M
  • GIII 557.6K
  • Earning Date
  • FTRE 03-03-2025
  • GIII 03-13-2025
  • Dividend Yield
  • FTRE N/A
  • GIII N/A
  • EPS Growth
  • FTRE N/A
  • GIII 12.00
  • EPS
  • FTRE N/A
  • GIII 4.20
  • Revenue
  • FTRE $2,696,400,000.00
  • GIII $3,180,796,000.00
  • Revenue This Year
  • FTRE N/A
  • GIII $3.70
  • Revenue Next Year
  • FTRE $5.67
  • GIII $2.77
  • P/E Ratio
  • FTRE N/A
  • GIII $6.36
  • Revenue Growth
  • FTRE N/A
  • GIII 2.66
  • 52 Week Low
  • FTRE $9.47
  • GIII $20.66
  • 52 Week High
  • FTRE $41.02
  • GIII $36.18
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 19.64
  • GIII 38.06
  • Support Level
  • FTRE $9.76
  • GIII $25.05
  • Resistance Level
  • FTRE $11.12
  • GIII $26.83
  • Average True Range (ATR)
  • FTRE 0.95
  • GIII 1.58
  • MACD
  • FTRE -0.24
  • GIII 0.01
  • Stochastic Oscillator
  • FTRE 1.75
  • GIII 21.26

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists primarily of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives most of its revenues from Wholesale operations.

Share on Social Networks: